Advertisement

Applied Microbiology and Biotechnology

, Volume 103, Issue 2, pp 685–694 | Cite as

Bacteriophage production processes

  • Katja Jurač
  • Dominik Nabergoj
  • Aleš PodgornikEmail author
Mini-Review

Abstract

High quantities of bacteriophages are currently used in the food industry and agriculture. However, growing antibiotic resistance of bacteria has recently awakened the interest to use bacteriophages for the treatment of bacterial infections in humans indicating that even higher quantities will be required in the future. High demand combined with a wide range of applications requires also efficient bacteriophage production processes operating at low production costs and with high productivity. To achieve this goal, different approaches were introduced and extensive studies of various parameters affecting bacteriophage formation were investigated. In this mini-review, we provide a short overview about different operation modes of bacteriophage production such as batch, semi-continuous and especially continuous with the pros and cons of each. We present factors affecting bacterial physiological state, its effect on phage formation and provide a description of methods for determination of bacteriophage growth parameters, through which bacteriophage formation is obtained. Understanding of described phenomena and inclusion of potential occurrence of mutations and selection in continuous systems enables evaluation of continuous process productivity and its optimization.

Keywords

Bacteriophage production Continuous bioprocess Bacteriophage growth parameters Bacteria physiological state 

Notes

Funding

The study was funded by the European Regional Development Fund and Slovenian Ministry of Education, Science and Sport (project BioPharm.Si).

Compliance with ethical standards

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Abedon ST (2018) Phage Companies. http://companies.phage.org/. Accessed 14 June 2018
  2. Abedon ST, Herschler TD, Stopar D (2001) Bacteriophage latent-period evolution as a response to resource availability. Appl Environ Microbiol 67:4233–4241Google Scholar
  3. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM (2011) Phage treatment of human infections. Bacteriophage 1:66–85.  https://doi.org/10.4161/bact.1.2.15845 Google Scholar
  4. Adams MH (1959) Bacteriophages. Interscience publishers, Inc., New YorkGoogle Scholar
  5. Agboluaje M, Sauvageau D (2018) Bacteriophage production in bioreactors. In: Azeredo J, Sillankorva S (eds) Bacteriophage therapy. Methods in molecular biology, vol 1693. Humana Press, New York, pp 173–193. doi:  https://doi.org/10.1007/978-1-4939-7395-8_15
  6. Ahmed K, Kaderbhai NN, Kaderbhai MA (2012) Bacteriophage therapy revisited. African J Microbiol Res 6:3366–3379.  https://doi.org/10.5897/AJMR11.968 Google Scholar
  7. Aita T, Husimi Y (1994) Period dependent selection in continuous culture of viruses in a periodic environment. J Theor Biol 168:281–289.  https://doi.org/10.1006/jtbi.1994.1109 Google Scholar
  8. AmpliPhi Biosciences Corporation (2018) http://www.ampliphibio.com/about-us/. Accessed 28 June 2018
  9. Anderson TF (1949) The reactions of bacterial viruses with their host cells. Bot Rev 15:464–505.  https://doi.org/10.1007/BF02861677 Google Scholar
  10. Balogh B, Jones JB, Iriarte FB, Momol MT (2010) Phage therapy for plant disease control. Curr Pharm Biotechnol 11:48–57Google Scholar
  11. Barrow PA (2001) The use of bacteriophages for treatment and prevention of bacterial disease in animals and animal models of human infection. J Chem Technol Biotechnol 76:677–682.  https://doi.org/10.1002/jctb.436 Google Scholar
  12. Bohannan BJM, Lenski RE (1997) Effect of resource enrichment on a chemostat community of bacteria and bacteriophage. Ecology 78:2303–2315Google Scholar
  13. Bohannan BJM, Lenski RE (2000) The relative importance of competition and predation varies with productivity in a model community. Am Nat 156:329–340.  https://doi.org/10.1086/303393 Google Scholar
  14. Branston S, Stanley E, Ward J, Keshavarz-Moore E (2011) Study of robustness of filamentous bacteriophages for industrial applications. Biotechnol Bioeng 108:1468–1472.  https://doi.org/10.1002/bit.23066 Google Scholar
  15. Bryan D, El-Shibiny A, Hobbs Z, Porter J, Kutter EM (2016) Bacteriophage T4 infection of stationary phase E. coli: life after log from a phage perspective. Front Microbiol 7:1391.  https://doi.org/10.3389/fmicb.2016.01391 Google Scholar
  16. Bull JJ (2006) Optimality models of phage life history and parallels in disease evolution. J Theor Biol 241:928–938.  https://doi.org/10.1016/j.jtbi.2006.01.027 Google Scholar
  17. Bull JJ, Millstein J, Orcutt J, Wichman HA (2006) Evolutionary feedback mediated through population density, illustrated with viruses in chemostats. Am Nat 167:E39–E51.  https://doi.org/10.1086/499374 Google Scholar
  18. Campbell A (1961) Conditions for the existence of bacteriophage. Evolution 15:153–165.  https://doi.org/10.2307/2406076 Google Scholar
  19. Chan BK, Abedon ST, Loc-Carrillo C (2013) Phage cocktails and the future of phage therapy. Future Microbiol 8:769–783.  https://doi.org/10.2217/fmb.13.47 Google Scholar
  20. Chao L, Levin BR, Stewart FM (1977) A complex community in a simple habitat: an experimental study with bacteria and phage. Ecology 58:369–378.  https://doi.org/10.2307/1935611 Google Scholar
  21. Chibeu A, Agius L, Gao A, Sabour PM, Kropinski AM, Balamurugan S (2013) Efficacy of bacteriophage LISTEX™P100 combined with chemical antimicrobials in reducing Listeria monocytogenes in cooked turkey and roast beef. Int J Food Microbiol 167:208–214.  https://doi.org/10.1016/j.ijfoodmicro.2013.08.018 Google Scholar
  22. Choi C, Kuatsjah E, Wu E, Yuan S (2010) The effect of cell size on the burst size of T4 bacteriophage infections of Escherichia coli B23. J Exp Microbiol Immunol 14:85–91Google Scholar
  23. Clark JR, March JB (2006) Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol 24:212–218.  https://doi.org/10.1016/j.tibtech.2006.03.003 Google Scholar
  24. Clark DW, Meyer H-P, Leist C, Fiechter A (1986) Effects of growth medium on phage production and induction in Escherichia coli K-12 lambda lysogens. J Biotechnol 3:271–280.  https://doi.org/10.1016/0168-1656(86)90009-X Google Scholar
  25. Clokie MRJ, Millard AD, Letarov AV, Heaphy S (2011) Phages in nature. Bacteriophage 1:31–45.  https://doi.org/10.4161/bact.1.1.14942 Google Scholar
  26. Criscuolo E, Spadini S, Lamanna J, Ferro M, Burioni R (2017) Bacteriophages and their immunological applications against infectious threats. J Immunol Res 2017:1–13.  https://doi.org/10.1155/2017/3780697 Google Scholar
  27. De Czekala A, Luk D, Bartl P (1972) Large-scale production of lambda bacteriophage and purified lambda deoxyribonucleic acid. Appl Microbiol 23:791–795Google Scholar
  28. Dennehy JJ (2012) What can phages tell us about host-pathogen coevolution? Int J Evol Biol 2012:1–12.  https://doi.org/10.1155/2012/396165 Google Scholar
  29. d'Herelle F (1917) An invisible microbe that is antagonistic to the dysentery bacillus. C R Acad Sci 165:373–375Google Scholar
  30. Domingo E, Sabo D, Taniguchi T, Weissmann C (1978) Nucleotide sequence heterogeneity of an RNA phage population. Cell 13:735–744Google Scholar
  31. Dunn IJ, Heinzle E, Přenosil JE, Ingham J (1992) Biological reaction engineering : principles, applications and modelling with PC simulation. Wiley-VCH, WeinheimGoogle Scholar
  32. Egli T (2015) Microbial growth and physiology: a call for better craftsmanship. Front Microbiol 6:287.  https://doi.org/10.3389/fmicb.2015.00287 Google Scholar
  33. Ellis EL, Delbrück M (1939) The growth of bacteriophage. J Gen Physiol 22:365–384Google Scholar
  34. Fister S, Robben C, Witte AK, Schoder D, Wagner M, Rossmanith P (2016) Influence of environmental factors on phage–bacteria interaction and on the efficacy and infectivity of phage P100. Front Microbiol 7:1152.  https://doi.org/10.3389/fmicb.2016.01152 Google Scholar
  35. Fong SA, Drilling A, Morales S, Cornet ME, Woodworth BA, Fokkens WJ, Psaltis AJ, Vreugde S, Wormald P-J (2017) Activity of bacteriophages in removing biofilms of Pseudomonas aeruginosa isolates from chronic rhinosinusitis patients. Front Cell Infect Microbiol 7:418.  https://doi.org/10.3389/fcimb.2017.00418 Google Scholar
  36. Forde SE, Thompson JN, Holt RD, Bohannan BJM (2008) Coevolution drives temporal changes in fitness and diversity across environments in a bacteria-bacteriophage interaction. Evolution 62:1830–1839.  https://doi.org/10.1111/j.1558-5646.2008.00411.x Google Scholar
  37. García P, Martínez B, Obeso JM, Rodríguez A (2008) Bacteriophages and their application in food safety. Lett Appl Microbiol 47:479–485.  https://doi.org/10.1111/j.1472-765X.2008.02458.x Google Scholar
  38. Gáspár S, Rontó G, Müller G (1979) Determination of the biological parameters of bacterium-phage complexes. Z Allg Mikrobiol 19:163–169Google Scholar
  39. Gáspár S, Módos K, Gy R (1981) Complex method for the determinaton of the physiological parameters of bacterium-phage systems. In: Fedina L, Kanyár B, Kocsis B, Kollai M (eds) Mathematical and Computational methods in Physiology. Pergamon Press, Akadémiai Kiadó, Hungary, pp 141–146Google Scholar
  40. Golec P, Karczewska-Golec J, Łoś M, Węgrzyn G (2014) Bacteriophage T4 can produce progeny virions in extremely slowly growing Escherichia coli host: comparison of a mathematical model with the experimental data. FEMS Microbiol Lett 351:156–161.  https://doi.org/10.1111/1574-6968.12372 Google Scholar
  41. Grossi GF, Cesareni G, Liello F (1977) Development of phage populations in a bacterial culture: a mathematical model. Z Naturforsch C 32:844–849Google Scholar
  42. Guttman B, Raya R, Kutter E (2005) Basic phage biology. In: Kutter E, Sulakvelidze A (eds) Bacteriophages: biology and applications. CRC Press, Boca Raton, pp 29–66Google Scholar
  43. Hadas H, Einav M, Fishov I, Zaritsky A (1997) Bacteriophage T4 development depends on the physiology of its host Escherichia coli. Microbiology 143:179–185.  https://doi.org/10.1099/00221287-143-1-179 Google Scholar
  44. Hagens S, Loessner MJ (2007) Application of bacteriophages for detection and control of foodborne pathogens. Appl Microbiol Biotechnol 76:513–519.  https://doi.org/10.1007/s00253-007-1031-8 Google Scholar
  45. Hagens S, Loessner MJ (2014) Phages of Listeria offer novel tools for diagnostics and biocontrol. Front Microbiol 5:159.  https://doi.org/10.3389/fmicb.2014.00159 Google Scholar
  46. Haq IU, Chaudhry WN, Akhtar MN, Andleeb S, Qadri I (2012) Bacteriophages and their implications on future biotechnology: a review. Virol J 9:9.  https://doi.org/10.1186/1743-422X-9-9 Google Scholar
  47. Harrison E, Brockhurst MA (2017) Ecological and evolutionary benefits of temperate phage: what does or doesn’t kill you makes you stronger. BioEssays 39.  https://doi.org/10.1002/bies.201700112
  48. Husimi Y (1989) Selection and evolution of bacteriophages in cellstat. Adv Biophys 25:1–43Google Scholar
  49. Husimi Y, Nishigaki K, Kinoshita Y, Tanaka T (1982) Cellstat-a continuous culture system of a bacteriophage for the study of the mutation rate and the selection process of the DNA level. Rev Sci Instrum 53:517–522Google Scholar
  50. Husimi Y, Mori T, Ushijima S, Aita T (1993) Modes of population changeovers in continuous culture of bacterial and viral mutants spectrum. J Theor Biol 165:577–591.  https://doi.org/10.1006/jtbi.1993.1208 Google Scholar
  51. Hyman P, Abedon ST (2009) Practical methods for determining phage growth parameters. In: Clokie MRJ, Kropinski AM (eds) Bacteriophages: methods and protocols, Vol 1: isolation, characterization, and interactions. Humana Press, pp 175–202Google Scholar
  52. Jacobson H, Jacobson LS (1966) Virustat, a device for continuous production of viruses. Appl Microbiol 14:940–952Google Scholar
  53. Jensen KC, Hair BB, Wienclaw TM, Murdock MH, Hatch JB, Trent AT, White TD, Haskell KJ, Berges BK (2015) Isolation and host range of bacteriophage with lytic activity against methicillin-resistant Staphylococcus aureus and potential use as a fomite decontaminant. PLoS One 10:e0131714.  https://doi.org/10.1371/journal.pone.0131714 Google Scholar
  54. Jones JB, Jackson LE, Balogh B, Obradovic A, Iriarte FB, Momol MT (2007) Bacteriophages for plant disease control. Annu Rev Phytopathol 45:245–262.  https://doi.org/10.1146/annurev.phyto.45.062806.094411 Google Scholar
  55. Jungbauer A (2013) Continuous downstream processing of biopharmaceuticals. Trends Biotechnol 31:479–492.  https://doi.org/10.1016/j.tibtech.2013.05.011 Google Scholar
  56. Kick B, Behler KL, Severin TS, Weuster-Botz D (2017) Chemostat studies of bacteriophage M13 infected Escherichia coli JM109 for continuous ssDNA production. J Biotechnol 258:92–100.  https://doi.org/10.1016/j.jbiotec.2017.06.409 Google Scholar
  57. Kingwell K (2015) Bacteriophage therapies re-enter clinical trials. Nat Rev Drug Discov 14:515–516.  https://doi.org/10.1038/nrd4695 Google Scholar
  58. Kiros A, Gashaw T, Teshale A (2016) Phage therapy; a review on the biology and therapeutic application of bacteriophage. ARC J Anim Vet Sci 2:15–25.  https://doi.org/10.20431/2455-2518.0204003 Google Scholar
  59. Kolesnikova SG, Tulyakova EN, Moiseeva IY (2017) Phage therapy: present and future. J Phys Conf Ser 784:012027.  https://doi.org/10.1088/1742-6596/784/1/012027 Google Scholar
  60. Kong D, Yin J (1995) Whole-virus vaccine development by continuous culture on a complementing host. Biotechnology (NY) 13:583–558Google Scholar
  61. Koskella B, Brockhurst MA (2014) Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol Rev 38:916–931.  https://doi.org/10.1111/1574-6976.12072 Google Scholar
  62. Kropinski AM, Mazzocco A, Waddell TE, Lingohr E, Johnson RP (2009) Enumeration of bacteriophages by double agar overlay plaque assay. In: Clokie MRJ, Kropinski AM (eds) Bacteriophages: methods and protocols, vol 1: isolation, characterization, and interactions. Humana Press, pp 69–76Google Scholar
  63. Krysiak-Baltyn K, Martin GJO, Stickland AD, Scales PJ, Gras SL (2016) Computational models of populations of bacteria and lytic phage. Crit Rev Microbiol 42:942–968.  https://doi.org/10.3109/1040841X.2015.1114466 Google Scholar
  64. Krysiak-Baltyn K, Martin GJO, Gras SL (2018) Computational modelling of large scale phage production using a two-stage batch process. Pharmaceuticals (Basel) 11.  https://doi.org/10.3390/ph11020031
  65. Kunisaki H, Tanji Y (2010) Intercrossing of phage genomes in a phage cocktail and stable coexistence with Escherichia coli O157:H7 in anaerobic continuous culture. Appl Microbiol Biotechnol 85:1533–1540.  https://doi.org/10.1007/s00253-009-2230-2 Google Scholar
  66. Kutter E, Kellenberger E, Carlson K, Eddy S, Neitzel J, Messinger L, North J, Guttman B (1994) Effects of bacterial growth conditions and physiology on T4 infection. In: Karam JD (ed) Molecular biology of bacteriophage T4. American Society for Microbiology, Washington, DC, pp 406–418Google Scholar
  67. Labedan B, Legault-Demare J (1974) Evidence for heterogeneity in populations of T5 bacteriophage. J Virol 13:1093–1100Google Scholar
  68. Lenski RE (1988) Dynamics of interactions between bacteria and virulent bacteriophage. In: Marshall KC (ed) Advances in microbial ecology. Plenum Press, New York, pp 1–44.  https://doi.org/10.1007/978-1-4684-5409-3_1 Google Scholar
  69. Lenski RE, Levin BR (1985) Constraints on the coevolution of bacteria and virulent phage: a model, some experiments, and predictions for natural communities. Am Nat 125:585–602.  https://doi.org/10.2307/2461275 Google Scholar
  70. Letchumanan V, Chan KG, Pusparajah P, Saokaew S, Duangjai A, Goh BH, Ab Mutalib NS, Lee LH (2016) Insights into bacteriophage application in controlling Vibrio species. Front Microbiol 7:1114.  https://doi.org/10.3389/fmicb.2016.01114 Google Scholar
  71. Levenspiel O (1999) Chemical reaction engineering, 3rd edn. Wiley, New YorkGoogle Scholar
  72. Levin BR, Stewart FM, Chao L (1977) Resource-limited growth, competition, and predation: a model and experimental studies with bacteria and bacteriophage. Am Nat 111:3–24Google Scholar
  73. Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistence. World J Gastrointest Pharmacol Ther 8:162–173.  https://doi.org/10.4292/wjgpt.v8.i3.162 Google Scholar
  74. Lindberg HM, Mckean KA, Wang I-N (2014) Phage fitness may help predict phage therapy efficacy. Bacteriophage 4:e964081.  https://doi.org/10.4161/21597073.2014.964081 Google Scholar
  75. Lindemann BF, Klug C, Schwienhorst A (2002) Evolution of bacteriophage in continuous culture: a model system to test antiviral gene therapies for the emergence of phage escape mutants. J Virol 76:5784–5792.  https://doi.org/10.1128/JVI.76.11.5784-5792.2002 Google Scholar
  76. Lotka AJ (1925) Elements of physical biology. Williams and Wilkins, BaltimoreGoogle Scholar
  77. Ly-Chatain MH (2014) The factors affecting effectiveness of treatment in phages therapy. Front Microbiol 5.  https://doi.org/10.3389/fmicb.2014.00051
  78. Mancuso F, Shi J, Malik D (2018) High throughput manufacturing of bacteriophages using continuous stirred tank bioreactors connected in series to ensure optimum host bacteria physiology for phage production. Viruses 10:537.  https://doi.org/10.3390/v10100537 Google Scholar
  79. Marks T, Sharp R (2000) Bacteriophages and biotechnology: a review. J Chem Technol Biotechnol 75:6–17.  https://doi.org/10.1002/(SICI)1097-4660(200001)75:1<6::AID-JCTB157>3.0.CO;2-A Google Scholar
  80. Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, Imai S, Ikeuchi M, Tani T, Fujieda M, Wakiguchi H (2005) Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother 11:211–219.  https://doi.org/10.1007/s10156-005-0408-9 Google Scholar
  81. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Van Parys L, Lavigne R, Volckaert G, Mattheus W, Verween G, De Corte P, Rose T, Jennes S, Zizi M, De Vos D, Vaneechoutte M (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 4:e4944.  https://doi.org/10.1371/journal.pone.0004944 Google Scholar
  82. Mizoguchi K, Morita M, Fischer CR, Yoichi M, Tanji Y, Unno H (2003) Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl Environ Microbiol 69:170–176.  https://doi.org/10.1128/AEM.69.1.170-176.2003 Google Scholar
  83. Mojica KDA, Brussaard CPD (2014) Factors affecting virus dynamics and microbial host - virus interactions in marine environments. FEMS Microbiol Ecol 89:495–515.  https://doi.org/10.1111/1574-6941.12343 Google Scholar
  84. Monk AB, Rees CD, Barrow P, Hagens S, Harper DR (2010) Bacteriophage applications: where are we now? Lett Appl Microbiol 51:363–369.  https://doi.org/10.1111/j.1472-765X.2010.02916.x Google Scholar
  85. Nabergoj D, Kuzmić N, Drakslar B, Podgornik A (2018a) Effect of dilution rate on productivity of continuous bacteriophage production in cellstat. Appl Microbiol Biotechnol 102:3649–3661.  https://doi.org/10.1007/s00253-018-8893-9 Google Scholar
  86. Nabergoj D, Modic P, Podgornik A (2018b) Effect of bacterial growth rate on bacteriophage population growth rate. Microbiologyopen 7:e00558.  https://doi.org/10.1002/mbo3.558 Google Scholar
  87. Northrop JH (1938) Concentration and purification of bacteriophage. J Gen Physiol 21:335–366Google Scholar
  88. Novick A, Szilard L (1950) Experiments with the chemostat on spontaneous mutations of bacteria. Proc Natl Acad Sci U S A 36:708–719Google Scholar
  89. Pherecydes Pharma (2018) https://www.pherecydes-pharma.com/. Accessed 28 June 2018
  90. Podgornik A, Janež N, Smrekar F, Peterka M (2014) Continuous production of bacteriophages. In: Subramanian G (ed) Continuous processing in pharmaceutical manufacturing. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, pp 297–338Google Scholar
  91. Rathore AS (2015) Continuous processing for production of biotech therapeutics. PDA J Pharm Sci Technol 69:333.  https://doi.org/10.5731/pdajpst.2015.01072 Google Scholar
  92. Roach DR, Debarbieux L (2017) Phage therapy: awakening a sleeping giant. Emerg Top Life Sci 1:93–103.  https://doi.org/10.1042/ETLS20170002 Google Scholar
  93. Ross A, Ward S, Hyman P (2016) More is better: selecting for broad host range bacteriophages. Front Microbiol 7:1352.  https://doi.org/10.3389/fmicb.2016.01352 Google Scholar
  94. Roy B, Philippe C, Loessner M, Goulet J, Moineau S (2018) Production of bacteriophages by Listeria cells entrapped in organic polymers. Viruses 10:324.  https://doi.org/10.3390/v10060324 Google Scholar
  95. Santos SB, Carvalho C, Azeredo J, Ferreira EC (2014) Population dynamics of a Salmonella lytic phage and its host: implications of the host bacterial growth rate in modelling. PLoS One 9:e102507.  https://doi.org/10.1371/journal.pone.0102507 Google Scholar
  96. Sargeant K (1969) The deep culture of bacteriophage. In: Norris JR, Ribbons DW (eds) Methods in microbiology, vol 1. Academic Press, London, pp 505–520Google Scholar
  97. Sauvageau D, Cooper DG (2010) Two-stage, self-cycling process for the production of bacteriophages. Microb Cell Factories 9:81.  https://doi.org/10.1186/1475-2859-9-81 Google Scholar
  98. Schofield DA, Sharp NJ, Westwater C (2012) Phage-based platforms for the clinical detection of human bacterial pathogens. Bacteriophage 2:105–283.  https://doi.org/10.4161/bact.19274 Google Scholar
  99. Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T (2017) Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother 61:e00954–e00917.  https://doi.org/10.1128/AAC.00954-17 Google Scholar
  100. Schwienhorst A, Lindemann BF, Eigen M (1996) Growth kinetics of a bacteriophage in continuous culture. Biotechnol Bioeng 50:217–221.  https://doi.org/10.1002/bit.260500204 Google Scholar
  101. Shao Y, Wang I-N (2008) Bacteriophage adsorption rate and optimal lysis time. Genetics 180:471–482.  https://doi.org/10.1534/genetics.108.090100 Google Scholar
  102. Sharma S, Chatterjee S, Datta S, Prasad R, Dubey D, Prasad RK, Vairale MG (2017) Bacteriophages and its applications:an overview. Folia Microbiol (Praha) 62:17–55.  https://doi.org/10.1007/s12223-016-0471-x Google Scholar
  103. Smrekar F, Ciringer M, Peterka M, Podgornik A, Strancar A (2008) Purification and concentration of bacteriophage T4 using monolithic chromatographic supports. J Chromatogr B Analyt Technol Biomed Life Sci 861:177–180.  https://doi.org/10.1016/j.jchromb.2007.05.048 Google Scholar
  104. Spanakis E, Horne MT (1987) Co-adaptation of Escherichia coli and Coliphage λvir in continuous culture. J Gen Microbiol 133:353–360.  https://doi.org/10.1099/00221287-133-2-353 Google Scholar
  105. Storms ZJ, Sauvageau D (2014) Evidence that the heterogeneity of a T4 population is the result of heritable traits. PLoS One 9:e116235.  https://doi.org/10.1371/journal.pone.0116235 Google Scholar
  106. Storms ZJ, Sauvageau D (2015) Modeling tailed bacteriophage adsorption: insight into mechanisms. Virology 485:355–362.  https://doi.org/10.1016/j.virol.2015.08.007 Google Scholar
  107. Storms ZJ, Arsenault E, Sauvageau D, Cooper DG (2010) Bacteriophage adsorption efficiency and its effect on amplification. Bioprocess Biosyst Eng 33:823–831.  https://doi.org/10.1007/s00449-009-0405-y Google Scholar
  108. Storms ZJ, Brown T, Cooper DG, Sauvageau D, Leask RL (2013) Impact of the cell life-cycle on bacteriophage T4 infection. FEMS Microbiol Lett 353:63–68.  https://doi.org/10.1111/1574-6968.12402 Google Scholar
  109. Summers WC (2012) The strange history of phage therapy. Bacteriophage 2:130–133.  https://doi.org/10.4161/bact.20757 Google Scholar
  110. Taj MK, Ji X, Taj I, Hussani TM, Samreen Z, Wei Y (2013) Different phase Escherichia coli effect on T4 bacteriophage lysis and production. Int J Appl Nat Sci 2:73–76Google Scholar
  111. Tucker RG (1961) The role of magnesium ions in the growth of Salmonella phage anti-R. J Gen Microbiol 26:313–323.  https://doi.org/10.1099/00221287-26-2-313 Google Scholar
  112. Twort FW (1915) An investigation on the nature of ultra-microscopic viruses. Lancet 186:1241–1243.  https://doi.org/10.1016/S0140-6736(01)20383-3 Google Scholar
  113. Varon M (1979) Selection of predation-resistant bacteria in continuous culture. Nature 277:386–388.  https://doi.org/10.1038/277386a0 Google Scholar
  114. Volterra V (1926) Fluctuations in the abundance of a species considered mathematically. Nature 118:558–560Google Scholar
  115. Wang IN (2006) Lysis timing and bacteriophage fitness. Genetics 172:17–26.  https://doi.org/10.1534/genetics.105.045922 Google Scholar
  116. Warner CM, Barker N, Lee S-W, Perkins EJ (2014) M13 bacteriophage production for large-scale applications. Bioprocess Biosyst Eng 37:2067–2072.  https://doi.org/10.1007/s00449-014-1184-7 Google Scholar
  117. Weitz JS, Hartman H, Levin SA (2005) Coevolutionary arms races between bacteria and bacteriophage. PNAS 102:9535–9540.  https://doi.org/10.1073/pnas.0504062102 Google Scholar
  118. Wittebole X, De Roock S, Opal SM (2014) A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5:226–235.  https://doi.org/10.4161/viru.25991 Google Scholar
  119. Wright A, Hawkins CH, Änggård EE, Harper DR (2009) A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy. Clin Otolaryngol 34:349–357.  https://doi.org/10.1111/j.1749-4486.2009.01973.x Google Scholar
  120. Yosef I, Kiro R, Molshanski-Mor S, Edgar R, Qimron U (2014) Different approaches for using bacteriophages against antibiotic-resistant bacteria. Bacteriophage 4:e28491.  https://doi.org/10.4161/bact.28491 Google Scholar
  121. You L, Suthers PF, Yin J (2002) Effects of Escherichia coli physiology on growth of phage T7 in vivo and in silico. J Bacteriol 184:1888–1894.  https://doi.org/10.1128/JB.184.7.1888-1894.2002 Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Katja Jurač
    • 1
  • Dominik Nabergoj
    • 2
  • Aleš Podgornik
    • 1
    • 2
    Email author
  1. 1.Faculty of Chemistry and Chemical TechnologyUniversity of LjubljanaLjubljanaSlovenia
  2. 2.Center of Excellence for Biosensors, Instrumentation and Process Control – COBIKAjdovščinaSlovenia

Personalised recommendations